Immunohistochemical analysis of fifty-one high-grade astrocytoma samples for cellular localization of survivin revealed a significantly shorter overall survival in patients with tissue samples testing positive for both cytoplasmic and nuclear expression than with survivin expression of either location alone [47]. Here, BIRC5 is linked to astrocytoma (excluding glioblastoma).